Nesivine (Oxymetazoline Hydrochloride)

Oxymetazoline Hydrochloride, the active ingredient in Nesivine, is an alpha‑adrenergic agonist presented as a nasal spray for topical nasal use. It provides temporary relief of nasal congestion associated with the common cold, sinusitis, and allergic rhinitis in adults and children.

GNH USA supplies Nesivine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing consistent product quality, regulatory documentation, and reliable logistics for global distribution. The company adheres to EU GMP standards and offers technical support to procurement teams.

Oxymetazoline Hydrochloride is a topical nasal decongestant that reduces swelling of the nasal mucosa.

- Common cold: provides rapid reduction of nasal swelling, helping to clear blocked passages and improve breathing during viral upper respiratory infection. - Sinusitis: decreases mucosal edema, facilitating sinus drainage and relieving pressure associated with acute or chronic sinus inflammation. - Allergic rhinitis: alleviates congestion caused by allergic inflammation, improving airflow and reducing the sensation of a blocked nose.

Oxymetazoline Hydrochloride is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of the nasal mucosa - Sneezing or mild epistaxis - Headache - Transient taste disturbance - Rebound congestion with prolonged use (>3 days)

Serious or Rare Side Effects: - Severe hypertension or hypertensive crisis - Cardiac arrhythmias or palpitations - Chest pain or angina - Allergic reaction (rash, swelling, difficulty breathing) - Nasal ulceration or necrosis - Vision changes due to orbital involvement

When using Nesivine, consider the following safety measures.

- Duration of use: limit to three consecutive days to avoid rebound congestion. - Age restrictions: not recommended for children under six years unless directed by a healthcare professional. - Cardiovascular conditions: consult a physician if you have hypertension, heart disease, or arrhythmias. - Pregnancy and breastfeeding: discuss potential risks with a qualified healthcare provider before use. - Concomitant nasal products: avoid using other vasoconstrictive nasal sprays simultaneously. - Store at room temperature: keep in the original container, protect from moisture and direct heat.

Oxymetazoline may interact with other sympathomimetic agents and cardiovascular drugs.

Major Interactions (Avoid): - Oral decongestants (e.g., pseudoephedrine): additive systemic vasoconstriction may raise blood pressure. - Sympathomimetic agents (e.g., phenylephrine): increased risk of hypertensive events. - Monoamine oxidase inhibitors (MAOIs): potential for severe hypertension.

Moderate Interactions (Monitor Closely): - Antihypertensive medications: nasal vasoconstriction may reduce their effectiveness. - Beta‑blockers: may mask tachycardia caused by systemic absorption. - Tricyclic antidepressants: possible additive cardiovascular stimulation.